RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. RSLS:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Healthcare Industry: Medical Devices

0.0680 -0.01 (-12.26%)

Data as of Aug 21, 2019

Prev. Close 0.0775
Price Open 0.075
Volume 111,878
Day's Range 0.0667 - 0.075
52 Wk Range 0.041 - 11.199776
50 Day Moving Avg.
PE Ratio 0
Shares Outstanding 11.06M
Market Cap 751.76K

Trade RSLS stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Date	Research Firm	Action	Current	Target
8/03/18		Downgrades	BuyNeutral

The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering Shanthi RexalineWed, 14 Aug 2019 07:50:27 -0400
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout Shanthi RexalineWed, 07 Aug 2019 07:34:05 -0400
Reshape Lifesciences Q1 EPS $(0.54) Down From $(0.36) YoY, Sales $3.074M Up From $139K YoY Benzinga NewsdeskMon, 20 May 2019 16:23:11 -0400
ReShape Lifesciences FY18 Sales $2.8M Up From $2.3M YoY Benzinga NewsdeskMon, 01 Apr 2019 16:09:42 -0400
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs Shanthi RexalineSat, 30 Mar 2019 09:32:40 -0400
48 Biggest Movers From Friday Lisa LevinMon, 31 Dec 2018 06:18:32 -0400
Mid-Afternoon Market Update: Dow Rises 150 Points; Obalon Therapeutics Shares Plunge Lisa LevinFri, 28 Dec 2018 15:21:21 -0400
26 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 28 Dec 2018 13:43:17 -0400
Mid-Day Market Update: Crude Oil Up Over 1%; Quantum Shares Spike Higher Lisa LevinFri, 28 Dec 2018 13:18:02 -0400
Mid-Morning Market Update: Markets Open Higher; Opko Settles With SEC Lisa LevinFri, 28 Dec 2018 11:18:59 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

ReShape Lifesciences Announces Second Quarter 2019 Financial Results ACCESSWIRE6 days ago
ReShape Lifesciences to Host Second Quarter 2019 Conference Call on August 14, 2019 ACCESSWIREAug 08, 2019
ReShape Lifesciences Announces CFO Resignation ACCESSWIREAug 06, 2019
ReShape Lifesciences to Highlight LAP-Band Weight Loss Technology at ASMBS Spring Meeting ACCESSWIREJun 18, 2019
ReShape Lifesciences Announces $8 Million Private Placement ACCESSWIREJun 14, 2019
ReShape Lifesciences Strengthens Executive Leadership Team with Appointment of Kevin Condrin as Senior Vice President of Commercial ACCESSWIREJun 04, 2019
ReShape Lifesciences Announces First Quarter 2019 Financial Results ACCESSWIREMay 20, 2019
ReShape Lifesciences to Host First Quarter 2019 Conference Call on May 20, 2019 ACCESSWIREMay 20, 2019
ReShape Lifesciences Announces Distribution in Australia ACCESSWIREApr 18, 2019
ReShape Lifesciences Announces Fourth Quarter and Full Year 2018 Financial Results ACCESSWIREApr 01, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q2 2019 Results - Earnings Call Transcript Seeking Alpha6 days ago
ReShape Lifesciences reports Q2 results Seeking Alpha6 days ago
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q1 2019 Results - Earnings Call Transcript Seeking AlphaMay 20, 2019
ReShape Lifesciences reports Q1 results Seeking AlphaMay 20, 2019
ReShape Lifesciences Inc.'s (RSLS) CEO Dan Gladney on Q4 2018 Results - Earnings Call Transcript Seeking AlphaApr 01, 2019
ReShape Lifesciences reports Q4 results Seeking AlphaApr 01, 2019
ReShape Lifesciences announces $2M convertible note financing Seeking AlphaMar 29, 2019
New CEO at ReShape Lifesciences Seeking AlphaMar 26, 2019
ReShape Lifesciences' CEO bids adieu Seeking AlphaJan 28, 2019
Obalon Therapeutics: Playing The Aesthetics Business Seeking AlphaDec 24, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q2 2019	EST	Actual	Surprise
EPS:	Expected 2019-08-14
Rev:	Expected 2019-08-14

Q3 2019	EST	Actual	Surprise
EPS:	Expected 2019-11-13
Rev:	Expected 2019-11-13

Fastest Market News Application
You'll Hear It First On Pro

Company Profile

Visit company website

Brokerage Center

Compare All Online Brokerages

Market Overview

RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. RSLS:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

Membership is Free

What are you waiting for? Sign up now!

Free Account Login

Market Overview

Tickers

Articles

Keywords

RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. RSLS:OTCQB OTCQBEarly-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. RSLS:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.